Search

everythinglearnresearchcommunity

for

Search:↓

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Finasteride may help some women with hair loss, but better options exist.

Genetics affect early female hair loss, severity depends on duration, and low ferritin levels not significant.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Age, smoking, and lower BMI increase facial wrinkles; men wrinkle more than women, except in old age; pale skin and certain hormonal factors can protect against wrinkles.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

Birth control pills can help reduce mild to moderate acne in women.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

New treatments for PCOS focus on managing symptoms and improving fertility.

Women with PCOS have a higher risk of heart disease due to factors like insulin resistance and obesity.

The IRS-2 Asp/Asp genotype may increase the risk of PCOS in Chinese women, especially if they are not obese.

A higher testosterone to dihydrotestosterone ratio may indicate worse metabolic health in women.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Early diagnosis and treatment of PCOS in teenagers can help prevent more severe adult PCOS.